Get started
Author

Vittorio Del Fabro

Patients with bisphosphonates‐associated osteonecrosis of the jaw have reduced circulating endothelial cells
2007 · A Allegra, G Oteri, et al. · Hematological Oncology · 67
Influence of complex variant chromosomal translocations in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
2010 · Fabio Stagno, Paolo Vigneri, et al. · Acta Oncologica · 53
PDF
Differential levels of soluble angiopoietin‐2 and Tie‐2 in patients with haematological malignancies
2006 · E. Quartarone, A. Alonci, et al. · European Journal Of Haematology · 40
Emergencies in Hematology: Why, When and How I Treat?
2024 · Andrea Duminuco, Vittorio Del Fabro, et al. · Journal of Clinical Medicine · 30
PDF
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network
2019 · Concetta Conticello, Alessandra Romano, et al. · Journal of Clinical Medicine · 27
PDF
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno‐microenvironment in multiple myeloma
2023 · Alessandro Barbato, Cesarina Giallongo, et al. · Cell Proliferation · 24
PDF
Efficacy and safety of tixagevimab‐cilgavimab versus SARS‐CoV‐2 breakthrough infection in the hematological conditions
2023 · Andrea Duminuco, Antonella Nardo, et al. · Cancer · 20
PDF
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3
2019 · Fabrizio Puglisi, Nunziatina Parrinello, et al. · International Journal of Molecular Sciences · 19
PDF
Diffuse large B-cell lymphoma in the new era: prognostic tools for mapping risk
2025 · Andrea Duminuco, Salvatore Scarso, et al. · Annals of Hematology · 17
PDF
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis
2025 · Mariarita Spampinato, Cesarina Giallongo, et al. · Journal of Translational Medicine · 17
PDF
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab
2023 · Andrea Duminuco, Alessandra Romano, et al. · Frontiers in Oncology · 14
PDF
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
2019 · Marina Silvia Parisi, Salvatore Leotta, et al. · Journal of Clinical Medicine · 14
PDF
Imatinib dose escalation in 74 failure or suboptimal response chronic myeloid leukaemia patients at 3‐year follow‐up
2010 · Massimo Breccia, Fabio Stagno, et al. · American Journal of Hematology · 13
PDF
Multiple Myeloma in 2023 Ways: From Trials to Real Life
2023 · Manlio Fazio, Vittorio Del Fabro, et al. · Current Oncology · 12
PDF
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey
2021 · Uros Markovic, Alessandra Romano, et al. · Frontiers in Oncology · 12
PDF
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
2020 · Marzia Varettoni, Angela Ferrari, et al. · American Journal of Hematology · 12
PDF
Serum levels of interleukin-16 in lymphoid malignancies
2007 · G. Bellomo, A. Allegra, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias
2009 · Fabio Stagno, Paolo Vigneri, et al. · Acta Oncologica · 10
PDF
Serum free light chains and multiple myeloma: Is it time to extend their application?
2020 · Uros Markovic, Valerio Leotta, et al. · Clinical Case Reports · 9
PDF
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study
2023 · Vittorio Del Fabro, Mary Ann Di Giorgio, et al. · Cancers · 8
PDF
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells
2011 · Cesarina Giallongo, Piera La Cava, et al. · European Journal Of Haematology · 8
Aberrant Phenotypic Expression of the T-Cell-Associated Antigen CD8 on B-Cell Chronic Lymphocytic Leukemia Cells
2009 · Fabio Stagno, Anna Triolo, et al. · Laboratory Hematology · 8
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
2024 · Mariarita Spampinato, Tatiana Zuppelli, et al. · Pharmaceuticals · 7
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape
2025 · Andrea Duminuco, Patrick Harrington, et al. · Pharmaceuticals · 5
PDF
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia
2023 · Daniela Cambria, Lucia Longhitano, et al. · Life · 5
PDF
Works count: 89
Citation count: 516
H-index: 13
I10-index: 18
Year
Topic
Type